Angiogenic Factors, Inflammation, and Outcomes in Myeloablative Allogeneic Hematopoietic Cell Transplantation: A Biomarker Analysis of Gvhd Prophylaxis in Blood and Marrow Transplant Clinical Trials Network Protocol (BMT CTN) 0402
2016 ◽
Vol 22
(3)
◽
pp. S70-S71
◽
2017 ◽
Vol 23
(3)
◽
pp. S73-S74
2015 ◽
Vol 21
(3)
◽
pp. 454-459
◽
2017 ◽
Vol 23
(1)
◽
pp. 161-164
◽
2018 ◽
Vol 24
(4)
◽
pp. 700-707
◽
2009 ◽
Vol 15
(7)
◽
pp. 864-871
◽
2016 ◽
Vol 22
(10)
◽
pp. 1747-1757
◽
2016 ◽
Vol 22
(11)
◽
pp. 2077-2083
◽
2014 ◽
Vol 20
(10)
◽
pp. 1530-1536
◽
2017 ◽
Vol 23
(5)
◽
pp. 853-856
◽